Literature DB >> 19765410

The Brazilian consensus on the management of Pompe disease.

Juan C Llerena1, Dafne Maria Horovitz, Suely Kazue Nagahashi Marie, Gilda Porta, Roberto Giugliani, Maria Verónica Muñoz Rojas, Ana Maria Martins.   

Abstract

Mesh:

Year:  2009        PMID: 19765410     DOI: 10.1016/j.jpeds.2009.07.006

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  7 in total

Review 1.  [Diagnosis and therapy of late onset Pompe disease].

Authors:  A Schüller; C Kornblum; M Deschauer; M Vorgerd; B Schrank; E Mengel; Z Lukacs; D Gläser; P Young; U Plöckinger; B Schoser
Journal:  Nervenarzt       Date:  2013-12       Impact factor: 1.214

2.  Outcome of patients with classical infantile pompe disease receiving enzyme replacement therapy in Germany.

Authors:  Andreas Hahn; Susanne Praetorius; Nesrin Karabul; Johanna Dießel; Dorle Schmidt; Reinald Motz; Claudia Haase; Martina Baethmann; Julia B Hennermann; Martin Smitka; René Santer; Nicole Muschol; Ann Meyer; Thorsten Marquardt; Martina Huemer; Charlotte Thiels; Marianne Rohrbach; Gökce Seyfullah; Eugen Mengel
Journal:  JIMD Rep       Date:  2015-01-28

3.  Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease.

Authors:  Thomas Hundsberger; Marianne Rohrbach; Lukas Kern; Kai M Rösler
Journal:  J Neurol       Date:  2013-06-08       Impact factor: 4.849

4.  Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group.

Authors:  Fatma Al Jasmi; Mohammed Al Jumah; Fatimah Alqarni; Nouriya Al-Sanna'a; Fawziah Al-Sharif; Saeed Bohlega; Edward J Cupler; Waseem Fathalla; Mohamed A Hamdan; Nawal Makhseed; Shahriar Nafissi; Yalda Nilipour; Laila Selim; Nuri Shembesh; Rawda Sunbul; Seyed Hassan Tonekaboni
Journal:  BMC Neurol       Date:  2015-10-15       Impact factor: 2.474

5.  Respiratory manifestations in late-onset Pompe disease: a case series conducted in Brazil.

Authors:  Bruna de Souza Sixel; Luanda Dias da Silva; Nicolette Celani Cavalcanti; Glória Maria Cardoso de Andrade Penque; Sandra Lisboa; Dafne Dain Gandelman Horovitz; Juan Clinton Llerena
Journal:  J Bras Pneumol       Date:  2017 Jan-Feb       Impact factor: 2.624

6.  GAA variants and phenotypes among 1,079 patients with Pompe disease: Data from the Pompe Registry.

Authors:  Arnold J J Reuser; Ans T van der Ploeg; Yin-Hsiu Chien; Juan Llerena; Mary-Alice Abbott; Paula R Clemens; Virginia E Kimonis; Nancy Leslie; Sonia S Maruti; Bernd-Jan Sanson; Roberto Araujo; Magali Periquet; Antonio Toscano; Priya S Kishnani
Journal:  Hum Mutat       Date:  2019-08-07       Impact factor: 4.878

7.  Standardized nursing management of enzyme replacement therapy for late-onset Pompe disease.

Authors:  Shan Tang; Jiachu Ma; Huaxing Meng; Junhong Guo; Shuyan Cao; Binquan Wang
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.